Lawrence Feldman, Md

This study tested whether adding a new drug called Imprime PGG to an existing immunotherapy (pembrolizumab) could help control advanced lung cancer that had worsened after initial chemotherapy. It involved 35 adults with metastatic non-small cell lung cancer. The research first a…